Mirror-Image Comparison of Maintenance Electroconvulsive Treatment Effectiveness in Affective and Psychotic Disorders

Arda Bağcaz1, Koray Başar2

  • 1From the Department of Psychiatry, Başkent University Faculty of Medicine.

The Journal of ECT
|June 14, 2022
PubMed
Abstract

Insights

Maintenance electroconvulsive therapy (mECT) significantly reduces hospitalization frequency and duration in patients with affective and psychotic disorders. This treatment modality proves effective in managing long-term psychiatric conditions.

Area of Science:

  • Psychiatry
  • Neurology
  • Clinical Medicine

Background:

  • Electroconvulsive therapy (ECT) is a recognized treatment for severe psychiatric disorders.
  • Maintenance electroconvulsive therapy (mECT) aims to prevent relapse and recurrence after acute ECT treatment.
  • The effectiveness of mECT in reducing long-term healthcare utilization requires further investigation.

Purpose of the Study:

  • To evaluate the efficacy of maintenance electroconvulsive therapy (mECT) in reducing hospitalization duration and frequency.
  • To assess the impact of mECT on major and minor treatment changes in psychiatric patients.
  • To compare outcomes during mECT treatment versus the period preceding mECT.

Main Methods:

  • A retrospective mirror-image study design was employed, analyzing data from 36 patients with psychotic or affective disorders.
  • Patient medical records were reviewed for two equal-duration periods: before mECT (pre-mECT) and during mECT (post-mECT).
  • Hospitalization duration, number of hospitalizations, and treatment changes were recorded and statistically compared using generalized estimating equation models.

Main Results:

  • Maintenance electroconvulsive therapy (mECT), combined with pharmacotherapy, significantly decreased hospitalization frequency (RR, 0.161; P < 0.001) and duration (RR, 0.123; P < 0.001).
  • A significant reduction in major treatment changes was observed during mECT (RR, 0.522; P = 0.007).
  • Relapse and recurrence rates were comparable between patients with affective and psychotic disorders (26.3% vs 29.4%).

Conclusions:

  • Maintenance electroconvulsive therapy (mECT) is an effective treatment modality for reducing hospitalizations in patients with affective and psychotic disorders.
  • The findings support the continued consideration of mECT as a crucial long-term treatment option following successful acute ECT.
  • Individualized mECT schedules, alongside pharmacotherapy, contribute to improved patient outcomes and reduced healthcare resource utilization.

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
181
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
208
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
452
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318